NIPT Testing in India - Indispensable diagnostic tool used for detecting genetic

Posted by Genes2Me on January 9th, 2021

Detecting genetic abnormalities during pregnancy:

Genetic testing during pregnancy is an important perspective that mostly remains unexplored during pregnancy. Most genetic abnormalities can be detected using various diagnostic tools during pregnancy. The genetic testing tool estimates the risk of having a child with a genetic disorder, which can help the couple to make informed decisions.

Invasive and Non-Invasive diagnostic tools are used to detect if the child has a certain genetic disorder after birth. These tools can also be used to detect miscarriage and the reason for stillbirth. Genetic abnormalities during pregnancy include extra or missing chromosomal material, leading to the development of different genetic disorders such as Down syndrome, Patau Syndrome, and Edward syndrome. Other than these three syndromes, several other genetic abnormalities can develop in a foetus during pregnancy. Early diagnosis or detection of these abnormalities can help the concerned doctor design a specific plan for managing the disorder. 

Non-Invasive Prenatal Testing (NIPT) in India:

Non Invasive prenatal testing is an innovative genetic testing methodology that is being implemented by different genetic testing diagnostic companies to detect genetic abnormalities. In India, NIPT is being offered by the topmost genetic testing companies across the country. Genes2Me, one of the leading genetic testing companies, offers NIPT as a prominent tool for genetic testing during pregnancy. The name given to the test is ClaritNIPT. This test is recommended by top doctors and healthcare providers of the country. The test offers exceptional sensitivity and >99.9% accuracy in results, making it an inevitable test during pregnancy. The best part about this testing procedure is that it can be used as early as during the 10^th week of pregnancy. A couple can get in-depth insights regarding genetic and chromosomal abnormalities by getting this test done early during pregnancy.

Brief about NIPT: 

NIPT is a simple, non-invasive procedure that poses no risk to the developing baby and mother. The test uses the foetus’s cell-free DNA flowing in the maternal serum to check for chromosomal and genetic abnormalities. The test also avoids any risk of miscarriage or stillbirth, which can occur during invasive testing procedures. Non-invasive prenatal screening prominently looks for Trisomy 21 (Down syndrome), Trisomy 18 (Edward's Syndrome), and Trisomy 13 (Patau Syndrome). Genes2Me also offers full ClaritNIPT, which looks for other prominent aneuploidies and trisomy's other than the three mentioned above. This company's test also comes with a fast turnaround time of 8-10 days from the date of sample collection to report generation. Advanced and innovative Next Generation Sequencing (NGS) is used to process the patient's samples. In-depth reports are generated, which help the doctor and the patient manage the abnormalities and helps the couple make timely informed decisions. Pre and post genetic counselling option is also provided to the patients to be aware of the testing protocol and help them interpret results.

NIPT is the best example of a chromosomal test that is performed during pregnancy. Early diagnosis using this testing protocol can help in decreasing the risk of genetic abnormality in the new-born.

For more details, visit www.genes2me.com.